RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced study results in which opaganib, a leading oral drug candidate for hospitalized patients with moderate to...
RedHill Biopharma Ltd., a specialty biopharmaceutical company, announced that it has entered into an exclusive license agreement with Kukbo Co. Ltd., a South Korean...